Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, April 27, 2020
[ Mon, Apr 27th 2020
] - WOPRAI
[ Mon, Apr 27th 2020
] - WOPRAI
[ Mon, Apr 27th 2020
] - WOPRAI
[ Mon, Apr 27th 2020
] - WOPRAI
[ Mon, Apr 27th 2020
] - WOPRAI
[ Mon, Apr 27th 2020
] - WOPRAI
[ Mon, Apr 27th 2020
] - WOPRAI
[ Mon, Apr 27th 2020
] - WOPRAI
[ Mon, Apr 27th 2020
] - WOPRAI
[ Mon, Apr 27th 2020
] - WOPRAI
[ Mon, Apr 27th 2020
] - WOPRAI
[ Mon, Apr 27th 2020
] - WOPRAI
[ Mon, Apr 27th 2020
] - WOPRAI
[ Mon, Apr 27th 2020
] - WOPRAI
[ Mon, Apr 27th 2020
] - WOPRAI
[ Mon, Apr 27th 2020
] - WOPRAI
[ Mon, Apr 27th 2020
] - WOPRAI
[ Mon, Apr 27th 2020
] - WOPRAI
[ Mon, Apr 27th 2020
] - WOPRAI
[ Mon, Apr 27th 2020
] - WOPRAI
[ Mon, Apr 27th 2020
] - WOPRAI
[ Mon, Apr 27th 2020
] - WOPRAI
[ Mon, Apr 27th 2020
] - WOPRAI
[ Mon, Apr 27th 2020
] - WOPRAI
[ Mon, Apr 27th 2020
] - WOPRAI
[ Mon, Apr 27th 2020
] - WOPRAI
[ Mon, Apr 27th 2020
] - WOPRAI
Mohit Bansal Maintained (ADAP) at Strong Buy with Decreased Target to $5 on, Apr 27th, 2020
Mohit Bansal of Citigroup, Maintained "Adaptimmune Therapeutics plc" (ADAP) at Strong Buy with Decreased Target from $8 to $5 on, Apr 27th, 2020.
Mohit has made no other calls on ADAP in the last 4 months.
There is 1 other peer that has a rating on ADAP. Out of the 1 peers that are also analyzing ADAP, all agrees with Mohit's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Mara Goldstein of "Mizuho" Initiated at Hold and Held Target at $3 on, Wednesday, April 22nd, 2020
Similar Stocks and Investing Articles
[ Thu, Apr 23rd 2020
] - WOPRAI
[ Tue, Apr 21st 2020
] - WOPRAI
[ Tue, Apr 21st 2020
] - WOPRAI
[ Tue, Apr 14th 2020
] - WOPRAI
[ Mon, Apr 13th 2020
] - WOPRAI
[ Thu, Apr 09th 2020
] - WOPRAI
[ Fri, Apr 03rd 2020
] - WOPRAI
[ Thu, Apr 02nd 2020
] - WOPRAI
[ Thu, May 30th 2019
] - WOPRAI
[ Fri, Apr 27th 2018
] - WOPRAI